# Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis

Study · id `cardio:ct-nct06447701` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06447701](<https://clinicaltrials.gov/study/NCT06447701>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06447701

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 486 participants.

## Technical summary

Registry record NCT06447701. Randomized; quadruple masking; primary purpose treatment. Start 2025-10-30 (anticipated); primary completion 2025-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 486 participants (planned count; ClinicalTrials.gov record NCT06447701, source copy `cardio:ctgov-nct06447701-2025-07-28`, retrieved 2026-10-26)
- Planned start: 2025-10-30 (anticipated) (ClinicalTrials.gov record NCT06447701, source copy `cardio:ctgov-nct06447701-2025-07-28`, retrieved 2026-10-26)
- Primary completion: 2025-12-31 (anticipated) (ClinicalTrials.gov record NCT06447701, source copy `cardio:ctgov-nct06447701-2025-07-28`, retrieved 2026-10-26)
- Completion: 2029-06-30 (anticipated) (ClinicalTrials.gov record NCT06447701, source copy `cardio:ctgov-nct06447701-2025-07-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06447701-2025-07-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
- Acronym: IRIS-sICAS
- Condition: Brain Diseases
- Condition: Ischemic Stroke
- Condition: Ischemia
- Condition: Stroke
- Condition: Cerebral Infarction
- Condition: Atherosclerosis of Artery
- Condition: Atheroscleroses, Intracranial
- Intervention (Drug): Tocilizumab
- Intervention (Drug): NaCl 0.9% 100ml
- Lead sponsor: Zhujiang Hospital
- Lead sponsor class: OTHER
- Collaborator: Shenzhen Second People's Hospital
- Collaborator class: OTHER
- Collaborator: Central People's Hospital of Zhanjiang
- Collaborator class: OTHER
- Collaborator: Shantou Central Hospital
- Collaborator class: OTHER
- Collaborator: Eighth Affiliated Hospital, Sun Yat-sen University
- Collaborator class: OTHER
- Collaborator: Guangzhou First People's Hospital
- Collaborator class: OTHER
- Collaborator: Peking University Shenzhen Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong Provincial People's Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Zhujiang Hospital (`cardio:org-zhujiang-hospital`)
- Registry lists this organization as a collaborator: Shenzhen Second People's Hospital (`cardio:org-shenzhen-second-people-s-hospital`)
- Registry lists this organization as a collaborator: Eighth Affiliated Hospital, Sun Yat-sen University (`cardio:org-eighth-affiliated-hospital-sun-yat-sen-university`)
- Registry lists this organization as a collaborator: Guangzhou First People's Hospital (`cardio:org-guangzhou-first-people-s-hospital`)
- Registry lists this organization as a collaborator: Peking University Shenzhen Hospital (`cardio:org-peking-university-shenzhen-hospital`)
- Registry lists this organization as a collaborator: Guangdong Provincial People's Hospital (`cardio:org-guangdong-provincial-people-s-hospital`)

## Provenance

Content hash: acb801452a9866f666e24c9a90ba1caeaeab15e99925d55e1d6c63297c19fe7e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
